Industry News

AI-Powered Diagnostics Software Guides Cardiologists during Angiography

By Medimaging International staff writers
06 Nov 2019

Image: AutocathFFR, a fully automated system, is designed to detect stenoses (narrowing) in the coronary arteries surrounding the heart (Photo courtesy of MedHub).Researchers are in the initial stages of a pivotal multi-center clinical trial to demonstrate the efficacy of AutocathFFR, a fully automated system that detects stenoses (narrowing) in the coronary arteries surrounding the heart. AutocathFFR provides cardiologists with the relevant physiological parameters that can help them in assessing the severity of their patients' condition and devise the optimal treatment strategy.

The artificial intelligence (AI) powered software has been developed by MedHub (Tel Aviv, Israel), which develops decision-support systems for cardiologists that leverage AI to guide cardiologists during the diagnostic cardiac angiography process. MedHub considers its first product, AutocathFFR, as a part of the current movement towards automizing medical practices. With the advent of AI, the road to full Robotic Process Automation (RPA) in cardiac diagnostics is getting shorter. Following a successful feasibility study of AutocathFFR, MedHub is now in the process of conducting the pivotal multi-center clinical trial to demonstrate its efficacy.

"As interventional cardiologists performing catheterizations on a daily basis, we face significant challenges in accurate diagnosis of cardiac disease that stem from difficulty in precisely assessing the severity of a patient's condition and in making the appropriate connections between a patient's complaints and the subsequent diagnosis. This makes tailoring an optimal and personalized course of treatment difficult, at best," said Dr. Edward Koifman, a senior cardiologist at Soroka Medical Center, and CMO of MedHub. "AI is revolutionizing medicine. We are already seeing its impact on diagnosis and treatment precision in a variety of medical fields. I believe that this kind of technology will assist cardiologists in the decision-making process when determining the best course of action."

"Nowadays, we fly in automated airplanes and rely on smart navigation systems in our private cars to make better decisions than we do. I don't see why we shouldn't make use of similar capabilities when it comes to our health and well-being," said Or Bruch-El, CEO of MedHub. "Healthcare systems everywhere are burning-out and collapsing under immense loads, making quality of treatment directly dependent on patient access to private capital. AI has the potential to change that. Our reality calls for it."

Related Links:
MedHub



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

25 Nov 2019
LANDAUER and RaySafe Exhibit New Products and Services at RSNA 2019
 LANDAUER (Glenwood, IL, USA) and RaySafe (Billdal, Sweden) showcased several new products and services at the Radiological Society of North America (RSNA) 2019 Annual Meeting held on December 1-5 at McCormick Place in Chicago, USA.
Read More
07 Nov 2019
Global Automated Breast Ultrasound Systems Market to Surpass USD 1.8 Billion by 2025
The global automated breast ultrasound systems (ABUS) market was valued at over USD 0.68 billion in 2018 and is projected to grow at a CAGR 16.1% during the forecast period, 2019-2025 to surpass USD 1.8 billion by 2025, driven by increasing government expenditure and rising awareness about breast cancer. Initiatives such as free check-up camps and symposiums for raising awareness regarding early detection and diagnosis of breast cancer will lead to greater adoption of ABUS in the coming years. However, stringent regulations and guidelines for the approval of ABUS, coupled with the high cost of diagnostic procedure, could hamper the market growth during the forecast period.
Read More
07 Nov 2019
CT System Receives FDA Clearance for AI-Based Image Reconstruction Technology
Canon Medical Systems USA, Inc. (Tustin, CA, USA; www.us.medical.canon) has received 510(k) clearance for its Advanced Intelligent Clear-IQ Engine (AiCE) for the Aquilion Precision, further expanding access to its new deep convolutional neural network (DCNN) image reconstruction technology. The technology, which is now available on Canon’s Aquilion Precision and Aquilion ONE/GENESIS Edition CT systems, uses a deep learning algorithm to differentiate signal from noise so that it can suppress noise while enhancing signal, thus improving CT image reconstruction.
Read More
07 Nov 2019
AI-Powered MRI Image Enhancement Software Receives FDA Clearance
A new image processing software that utilizes proprietary deep learning algorithms to bring the latest imaging enhancement technology to existing scanners has received 510(k) clearance from the US Food and Drug Administration (FDA). The software named SubtleMR uses denoising and resolution enhancement to improve image quality and has been developed by Subtle Medical (Menlo Park, CA, USA; www.subtlemedical.com), a healthcare technology company focused on improving the quality, efficiency, and accessibility of medical imaging.
Read More
06 Nov 2019
UCSF Launches Artificial Intelligence Center to Advance Medical Imaging
The University of California San Francisco {(UCSF) San Francisco, CA, USA; www.ucsf.edu} has announced the launch of a new center to accelerate the application of artificial intelligence (AI) technology to radiology, leveraging advanced computational techniques and industry collaborations to improve patient diagnoses and care. The Center for Intelligent Imaging, or ci2, will develop and apply AI to devise powerful new ways to look inside the body and to evaluate health and disease. The center aims to enable transformation via intelligent radiology, with the goal of again collaborating with the industry to become of the first institutions to bring medical imaging AI to the bedside.
Read More
06 Nov 2019
Global Blood Gas and Electrolyte Analyzers Market to Surpass USD 2.1 Billion by 2025
The global blood gas and electrolyte analyzers market is projected to grow at a CAGR of 6.5% during the forecast period, 2018-2025 to reach a value of over USD 2.1 billion by 2025, driven mainly by the Bench Top segment which is anticipated to bring in healthy gains and add significant momentum to the market growth. The Bench Top segment is projected to grow at a CAGR of over 6.4% during the forecast period.
Read More
06 Nov 2019
IoT-Enabled Healthcare Equipment Market Projected to Reach USD 69.7 Billion by 2023
The global IoT-enabled healthcare equipment market is projected to grow at the rate of 29.9% annually from USD 18.8 billion in 2018 to USD 69.7 billion in 2023, driven by digitization during the forecast period. Medical devices companies are transforming from device or consumable providers to disease and care management organizations. Digitization in acute or chronic care is greatly aided by IoT-enabled medical devices, such as subcutaneous drug delivery units, continuous glucose monitors and vitals monitoring equipment. The emergence of digital enterprises such as Google and Apple in the consumer health space has led to development of new opportunities and innovations for medical devices companies.
Read More
05 Nov 2019
AI-Driven Software Uses CT Scans to Determine Extent of Brain Injury in Stroke Patients
A new study has shown that an artificial intelligence (AI) driven software can reliably tell doctors how much brain is injured in stroke patients using universally available CT scans, without the need for more complex advanced imaging.
Read More
05 Nov 2019
AI in Medicine Projected to Reach USD 17.02 Billion by 2024
The artificial intelligence (AI) in medicine market was valued at USD 2.24 billion in 2018 and is projected to register a CAGR of 40.15% during the forecast period, 2019-2024 to reach a value of USD 17.02 billion by 2024. The rapidly increasing adoption of cloud computing techniques has facilitated the adoption of AI solutions for mining large amounts of data to identify mistakes in the present scenarios and offer alternative solutions in complex situations.
Read More
Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions